A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

Serenity Health held its 4th annual Fentanyl Awareness Day event on Tuesday, April 29. Janice Thigpen is the first woman ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...

HPV-related throat cancers are rising, but risks can be lowered by avoiding tobacco, limiting alcohol, getting vaccinated, ...

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain ...

In general, head and neck cancers are treated with surgery, radiation, chemotherapy or a combination. However, head and neck ...

The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain ...

The FDA is currently reviewing Merck’s sBLA for Keytruda in head and neck cancer, with a target action date of June 23.

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

In the fight against cancer, researchers continue to look for everyday habits that might make a difference. A recent global ...

Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head ...